Proceedings of the National Academy of Sciences · 2018 · 55 citations · 30 references
Life SciencesMolecular BiologyCell SignalingMolecular PharmacologySignal TransductionCell Signaling NetworksReceptor PhysiologyReceptor RegulationPhosphatidylinositol 3-Kinase Signaling ComplexesPhosphoinositide 3-Kinase PathwayPhosphoinositide 3-Kinase SignalingPi3 Kinase-akt SignalingPi3k SignalingPi3k-akt Signaling Pathway
Significance The class IA PI3Ks, comprised of regulatory (p85α/p85β/p55γ) and catalytic (p110α/β/δ) subunits, which make the signaling lipid PIP 3 , constitute a key node in signaling. Many factors underlie their numerous cellular roles and large investments in the creation of PI3K-inhibitors. The existence of heterodimeric-isoforms (at least nine) with distinct distributions and properties and the often-debated existence of “p110-free-regulatory-subunits” as modulators provide the system with flexibility, redundancy and isoform-selective functions. Despite the scale of this endeavour, many of the system’s “rules of engagement” are unknown. Here we demonstrate preferential subunit associations, clarify the existence of “p110-free-regulatory-subunits”, show that they have properties that could allow them to modulate pathway activity, and reveal mechanisms that allow selective activation of PI3Kα and β by receptors.
30
SH2 domains recognize specific phosphopeptide sequences
Cell · 1993 · 2.7K citations
Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice
Klaus Okkenhaug, Antonio Bilancio, Géraldine Farjot et al. · Science · 2002 · 937 citations
Impaired B Cell Development and Proliferation in Absence of Phosphoinositide 3-Kinase p85α
Scott B. Snapper, Claudine M. Yballe, Laurie A. Davidson et al. · Science · 1999 · 631 citations
Life Sciences, Genetics, Immunology +17
Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice
Surbhi Gupta, Antoine R. Ramjaun, Paula Haiko et al. · Cell · 2007 · 591 citations · Full text
Medicine, Cancer Biology, Oncology +14